In a study of adipose mass, growth therapy treatment for 26 weeks resulted in: Subcutaneous fat mass decreased by 13% Intra-abdominal fat mass reduced by 30% Lean body mass increased by 3-11% Aerobic function improved by 11-19% Muscle strength increased by 7-19% These changes continued during one year of treatment resulting in a 22% reduction in overall fat mass and a 61% reduction in belly fat
So far, injectable options like Wegovy (semaglutide) and Zepbound (tirzepatide) have led the way
Other Investigations: Survodutide has shown positive outcomes in metabolic dysfunction-associated steatohepatitis (MASH) trials, meeting endpoints for liver fat and fibrosis improvements, suggesting broader cardiometabolic potential
Evidence exists for individual ingredients through separate clinical and preclinical studies, but the blend as a combined injectable preparation has not been formally evaluated in a controlled trial
The purpose of our Lipotropic and Vitamin B12 injections is to improve energy levels, boost metabolism and help burn fat
Research-grade IGF-1 DES is available only to qualified, licensed medical professionals